Introduction
Transverse tubules (t-tubules) are extensions of the plasma membrane that penetrate the cardiac myocyte, forming electrical connections between the surface membrane, and the sarcoplasmic reticulum (SR) called cardiac junctions that enable synchronized calcium release and hence contraction. 1, 2 These junctions constitute a nanoscale interface between the plasma and SR membranes and their remodelling appears to play a major role in the pathogenesis of heart failure. 3, 4 Experiments in animal models have demonstrated that t-tubule structure becomes disrupted in heart failure leading to disrupted SR calcium release, and reducing contractile function. to contribute to the loss of contractile function in human heart failure. [12] [13] [14] [15] [16] [17] [18] [19] Intracellular proteins that align plasma and SR membranes have been implicated in t-tubule remodelling. [20] [21] [22] [23] [24] [25] [26] However, our previous work suggested that the extracellular matrix may also be directly involved. We have previously documented enlargement and disarrangement of t-tubules in the failing human heart using confocal imaging of tissue sections labelled with wheat germ agglutinin (WGA). 17, 18 WGA is thought to bind to glycosylated proteins in the extra cellular matrix including those of the dystrophin glycoprotein complex (DGC). 27 This complex is critical to normal muscle function. Mutations in the genes encoding this complex lead to muscular dystrophy and to heart failure in older patients. 28, 29 The DGC forms a mechanical connection between the cytoskeleton and the extracellular matrix (ECM) and is therefore essential for transmitting force during muscle contraction. 29 Changes in dystrophin have been observed in end-stage human heart failure 30 and dystrophin remodelling is associated with hypertrophied t-tubules in the failing human heart. 31 We used liquid chromatography tandem mass spectrometry (LC MS/ MS) to investigate the increase in WGA labelling and identify a major component originating from type VI collagen (Col-VI), a collagen that when mutated can induce muscular dystrophy. 32 We investigated Col-VI and several other collagens (type IV (Col-IV) type III (Col-III) and type I (Col-I)) in human tissue samples and detected all of these collagens in the t-tubules using a combination of confocal and novel super-resolution methods. Our data support a new hypothesis that cardiac fibrosis not only contributes to expansion of the interstitial space but also to t-tubule remodelling in human heart failure.
Methods

Human heart samples
Human cardiac tissue from failing hearts was obtained from the Auckland City Hospital transplant program. Non-failing human LV samples from organ donors were obtained from Organ Donation New Zealand, and from the University of Sydney in collaboration with St Vincent's Hospital, Sydney. All human tissue was obtained with written and informed consent from transplant recipients or families of organ donors in accordance to the declaration of Helsinki, institutional guidelines as approved by the Health and Disability Ethics Committees New Zealand (NTY/05/08/050/AM05), Human Research Ethics Committees at University of Sydney (2012/2814), and St Vincent's Hospital (H03/ 118). Details of the heart samples are presented in Table 1 . Note that the non-failing samples and IDCM samples were selected so they are of similar age and sex. For immunohistochemistry LV tissues were fixed in 2% paraformaldehyde in PBS for 1 h 4 C, cryoprotected in 30% sucrose, frozen with liquid nitrogen chilled isopentane, and stored at -80 C.
Samples for protein work were preserved in RNA later overnight at 4 C and then frozen in liquid nitrogen chilled isopentane and stored at -80 C. Samples from Sydney University were frozen directly in liquid nitrogen.
Immunofluorescence labelling
Frozen sections (10 mm) were mounted on coverslips, permeabilized with 1% triton X100 in PBS for 15 min, and blocked with FX signal enhancer (ThermoFisher) for 1 h. 
Confocal imaging and image processing
Samples were mounted in 90% glycerol in PBS. Confocal images were obtained on a Zeiss LSM 710 inverted confocal microscope. For t-tubule analysis 3D image stacks were collected with 63x NA 1.4 oil-immersion objective (80 x 80 x 300 nm pixel spacing). Image stacks were deconvolved as previously described. 33 T-tubule widths were estimated by obtaining a perpendicular line profile (400 nm wide) and fitting a Gaussian function using ImageJ and calculating the full width half maximum (FWHM). 17 For assessment of tissue fibrosis three 2D images 425 by 425 mm were collected for each heart with 20x 0.8 NA air objective at pixel spacing of 200 nm. Images were median filtered (2 x 2 pixel kernel) to reduce noise followed by thresholding at the modal intensity plus one standard deviation. Total percent of the resulting mask was used as metric of labelling area (see Supplementary material online, Figure S1 ). For the assessment of Col-VI positive fibroblasts, cell numbers were counted in five 2D images covering 169 x 169 mm collected from each heart with a 63x NA 1.4 oil objective. Fibroblasts were identified from vimentin labelling, a cytoskeletal protein found in fibroblasts but not myocytes. 34 A fibroblast was considered Col-VI positive if the vimentin labelling overlapped or colocalized with Col-VI labelling and the cell had a visible nucleus located in the interstitial space.
Super-resolution imaging (dSTORM)
Samples were mounted in dSTORM imaging media consisting of 90% glycerol and 10 mM MEA in PBS. 35 Sections were then imaged on a Nikon TE2000 inverted total internal reflection fluorescence (TIRF) microscope modified for localization microscopy as previously described. 36 Briefly, a solid-state 671 nm laser (Viasho, China) was focused onto the sample via a 60x NA 1.49 oil-immersion TIRF objective (Nikon) in a highly inclined light sheet. 37 Emission light was passed through a Q680LP dichroic mirror (Chroma Technology) and an XF3104-690ALP emission filter (Omega optical) prior to being split into two spectral channels. dSTORM optical sections of transversely orientated myocytes were acquired for 20 000-40 000 frames at a rate of 50 ms per frame. The emission light for the two channels was recorded onto the two halves of the cooled EM-CCD chip of an IXon DV887DCS-BV camera (Andor Technology, Belfast).
dSTORM image analysis
Single molecule events were localized and spectrally separated by analysing recorded image stacks using custom-written algorithms implemented in Python. 35, 36 Point data of each fluorophore is rendered onto 5 nm Â 5 nm/pixel 2D greyscale TIFF image using jittered triangulation.
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T-tubule widths were estimated from perpendicular line profiles. WGA and ColVI widths were estimated from calculating FWHM using fitted Gaussian parameters. For dystrophin where a double row of labelling was visible a Gaussian was fitted to each row and widths estimated from respective FWHM as illustrated, see Supplementary material online, Figure S2 .
Western blot and LC-MS/MS
Western blot and LC-MS/MS were carried out with standard protocols as described in the Supplementary material online and see Supplementary material online, Figure S3 . Briefly, homogenates of heart tissue were separated by SDS-PAGE, transferred to PVDF or nitrocellulose membranes. WGA positive proteins were detected by incubating blots with WGA Alexa Fluor 680 conjugate overnight. For mass spectrometry detection of Col-VI the $140 kDa WGA positive band was excised, trypsin digested and analysed by LCMS/MS (QSTAR XL) with the resulting spectra searched against NCBI's human protein database using Mascot software. Western for Col-VI involved incubating blots with Col-VI antibody (AB6588, Abcam raised against full length alpha-1(VI) chain) overnight followed by secondary antibodies labelled with Alexa Fluor 647 for 1 h.
Col-VI alpha chain analysis
Details of the analysis are described in the Supplementary material online. Briefly, homogenates of heart tissue were separated by SDS-PAGE. The $140 kDa region from the gel was excised, trypsin digested and analysed by LCMS/MS (Sciex TripleTOF 6600) with the resulting spectra searched against Uniprot's human protein database (Feb 2015, 89 796 entries) using ProteinPilot v5.0 software to identify proteins, including Col-VI alpha chains.
Statistics
Values presented are means ± SEM. Differences in t-tubule diameter between donor and IDCM were evaluated with 2 factor nested ANOVA (factor 1: group (donor vs. IDCM), factor 2: heart (with 30 replicate t-tubules in each heart for confocal data, and 3 replicate t-tubules in super-resolution data). P-values are reported for the first factor. Differences between sample means for westerns and mass spectrometry were tested with either student's t-test or an unequal variance t-test. The Bonferroni method was used to adjust for multiple comparisons. Statistical analyses were carried out using IBM SPSS Statistics (version 22) with P < 0.05 considered significant.
Results
WGA and dystrophin labelling of ttubules
Confocal imaging of donor human ventricle showed that the sarcolemma and t-tubules are both labelled with WGA and dystrophin antibodies ( Figure 1A ). However, WGA also labels the ECM whereas antibodies to dystrophin are restricted to near the sarcolemma, consistent with the intracellular location of dystrophins. 29 For the larger donor t-tubules there is a double row of dystrophin labelling that flanks WGA ( Figure 1A insert) consistent with two opposing sides of the curved ttubule membrane. However, for most t-tubules, WGA and dystrophin labelling cannot be resolved due to the confocal optical resolution limit ($250 nm). In IDCM tissue an increase in WGA labelling of the ECM, cell surface and t-tubules was observed. In the IDCM samples, dystrophin labelling was similarly restricted to the cell surface and t-tubules ( Figure 1B ). Many of these t-tubules were noticeably dilated with double rows of dystrophin flanking WGA labelling ( Figure 1B insert). As we and others observed before many failing myocytes have a reduced number or even an absence of t-tubules. 17, 18, 31 T-tubule diameters were quantified by their full width at half maximum (FWHM) estimated from a Gaussian function fitted to the intensity profile of t-tubules in confocal images of WGA and dystrophin. The distribution of widths for 150 donor tissue t-tubules (from 5 hearts) and 150 diseased t-tubules (from 5 hearts) are presented in Figure 1C . This analysis demonstrates diseased t-tubules are wider and have a larger distribution of diameters than donor t-tubules, consistent with our previous report. 17 The mean diameter of t-tubules estimated from WGA labelling in normal myocytes was 294 ± 13 nm compared to a significantly increased diameter of 436 ± 4 nm in IDCM myocytes (P < 0.001***, n = 5 donor hearts, n = 5 explanted hearts, 30 t-tubules measured for each heart). Similarly, the mean diameter of t-tubules estimated from dystrophin labelling in donor myocytes was 314 ± 6 nm, significantly smaller than the 417 ± 17 nm in the diseased myocytes (P < 0.0001***, n = 5 donor hearts, n = 5 explanted hearts, 30 t-tubules measured for each heart).
Super-resolution microscopy with $30 nm resolution was subsequently utilized to resolve the spatial distribution of WGA and dystrophin within t-tubules ( Figure 1E ). This revealed WGA was located predominately within the t-tubule lumen while dystrophin appears to be restricted to the t-tubular intracellular surface. In disease, t-tubule diameters were noticeably larger, an expansion that appeared to be associated with the increased WGA-positive proteins within the lumen. the confocal demonstrating a significant broadening of WGA-labelled ttubules in diseased hearts ( Figure 1F ). Super-resolution microscopy of dystrophin labelling showed a similar significant increase in t-tubule widths in the failing hearts ( Figure 1F ). Note the double row of dystrophin is clearly resolved allowing the t-tubule widths to be measured by fitting a Gaussian to each line of dystrophin and estimating the outside edge of the labelling from respective FWHM estimates (see Supplementary material online, Figure S2 ).
Western blotting and mass spectrometry
Western blotting was used to probe LV homogenates for WGApositive proteins (Figure 2A) . This analysis demonstrated a 1.7-fold elevation in WGA-positive proteins in IDCM samples measured by integrating total lane intensity ( Figure 2B ). In particular, a $140 kDa band was elevated 5.7-fold in diseased hearts ( Figure 2C ) which was subsequently excised and subjected to trypsin digest and tandem mass spectrometry to identify candidate glycoproteins which revealed Col-VI 39 as the only candidate. Subsequent western blots probed with an anti Col-VI antibody confirmed the $140 kDa band as Col-VI. Col-VI was elevated 2.4-fold in failing hearts ( Figure 2E ) with no apparent relationship between patient age or sex (see Supplementary material online, Figure S4 ). The ratio of WGA to Col-VI intensity was then calculated for the 140 kDa band and found to be elevated 3.2-fold in the IDCM samples indicating increased glycan content of Col-VI in IDCM ( Figure 2G ). We initially attempted to probe for Col-VI and WGA positive proteins in the same Figure S5 ). This result suggests steric hindrance by WGA prevents detection of Col-VI and is further evidence that WGA and Col-VI antibodies bind to the same protein target.
Col-VI alpha chain analysis
Our original LC MS/MS analysis identified a2(VI) chain within the 140 kDa WGA positive band. However, the Col-VI antibody used in western blotting is raised against full length a1(VI) chain. To unambiguously determine which Col-VI alpha chain is present within the 140 kDa WGA positive region the material from this region was re-assessed using a higher sensitivity LC MS/MS analysis. This investigation identified 100-200 unique proteins within the 140 kDa region in SDS PAGE gels from five normal donor hearts and 5 IDCM hearts. For each heart, three alpha chains were detected: a1(VI), a2(VI), and a3(VI). From the LC MS/MS data the approximate molar ratios of the alpha chains were calculated by normalizing to a1(VI) chain intensity values. For normal donor hearts this gave a ratio of 0.92 ± 0.4 for a2(VI), and 0.32 ± 0.08 for a3(VI).
IDCM hearts had a ratio of 0.96 ± 0.08 for a2(VI), and 0.56 ± 0.08 for a3(VI) (see Supplementary material online, Figure S6 ).
Col-VI and dystrophin labelling of ttubules
Confocal imaging revealed Col-VI labelling area was significantly increased in heart failure, particularly in the interstitial space between myocytes ( Figure 3A-C) . Col-VI had a similar distribution to WGA in the extracellular matrix, cell surface and t-tubules ( Figure 3D and E). Larger donor t-tubules labelled for Col-VI also appeared to be flanked by dystrophin labelling similar to that seen for WGA ( Figure 3D insert) . However, again the resolution limit prevented us from resolving the distribution of these labels within the smaller tubules. In IDCM hearts Col-VI labelling was noticeably increased including within the lumen of hypertrophied t-tubules that were clearly flanked by double rows of dystrophin labelling ( Figure 3E insert) . The distribution of t-tubules widths was assessed from confocal imaging of Col-VI labelling in 150 donor t-tubules (from 5 hearts) and 210 t-tubules from IDCM samples (from 7 hearts) and data are presented in Figure 1F . This analysis demonstrates that Col- VI has an increased width and larger distribution of sizes in diseased t-tubules consistent with our findings for WGA. The mean diameter of Col-VI t-tubules in donor myocytes was 272 ± 15 nm compared to significantly increased diameter of 328 ± 11 nm in IDCM myocytes (P = 0.014*, n = 5 donor hearts, n = 7 explanted hearts, 30 t-tubules measured for each heart). Super-resolution microscopy resolved the distributions of Col-VI and dystrophin, particularly in the smaller t-tubules ( Figure 3G and H) . These images confirmed the presence of Col-VI within the tubular lumen with a noticeable accumulation within the hypertrophied t-tubules in IDCM hearts ( Figure 3G and H inserts) . FWHM measurements demonstrated a significant increase in the distribution of Col-VI within the t-tubules in heart failure relative to donor hearts.
Col-IV, Col-III, and Col-I labelling of ttubules
Confocal imaging of tissue sections identified that all three of these additional collagens were also present within the t-tubules and that the diameter of the labelled area increased significantly in t-tubules from heart failure patients (Figure 4) . The mean diameter of Col-IV t-tubules in donor myocytes was 251 ± 17 nm compared to 314 ± 20 nm in IDCM myocytes (P = 0.04*, n = 5 donor hearts, n = 5 explanted hearts, 30 ttubules measured for each heart). The mean diameter of Col-III t-tubules in donor myocytes was 256 ± 10 nm compared to 396 ± 20 nm in IDCM myocytes (P = 0.001***, n as above). The mean diameter of Col-I ttubules in donor myocytes was 266 ± 12 nm compared to 392 ± 33 nm in IDCM myocytes (P = 0.006**, n as above). Super-resolution microscopy confirmed this finding ( Figure 5 ). The total interstitial area labelled by Col-IV, Col-III, and Col-I was assessed between normal donor and IDCM hearts ( Figure 6 ). This demonstrated a significant increase in area labelled by Col-I in heart failure samples but not Col-IV and Col-III ( Figure 6 ). As additional test of the presence of t-tubule collagen, tissue sections were probed with a non-antibody based method using the collagen-binding protein CNA35-mAmertrine. CNA35-mAmertrine is a recombinant protein based on collagen adhesion protein from the bacteria Staphylococcus aureus and the fluorescence protein mAmertrine. 40 Confocal imaging of this labelling also revealed positive labelling of ttubules including increased diameter of t-tubules in heart failure (see Supplementary material online, Figure S6 ).
Fiboroblasts and Col-VI
To determine if fibroblasts were a likely source of the increased Col-VI in heart failure the number of Col-VI positive fibroblasts were estimated in five normal donor hearts and five IDCM hearts ( Figure 7) . This analysis demonstrated a significant $40% increase in the number of fibroblasts positive to Col-VI in the failing heart. In two of the IDCM hearts we also observed several myocytes in which fibroblast filopodia projected into the lumen of larger t-tubules ( Figure 7E-H) .
Discussion
The data presented suggest a novel hypothesis that directly links fibrosis of the failing heart with cardiac myocyte t-tubule remodelling. Western blots demonstrate a 2.4-fold increase in Col-VI, which was consistent with significant increase in interstitial labelling measured with confocal microscopy. This increase seen in Col-VI is also consistent with increases in total collagen previously reported for IDCM. [41] [42] [43] Collagen accumulation is the major hall mark of fibrosis and the mechanisms driving changes in these classical fibrillar collagens 44 are also likely to drive the increase of Col-VI particularly as interstitial fibroblasts appear to be the major source of this collagen. 45 This is further supported by an increased tissue density of Col-VI positive fibroblasts that we have documented in IDCM hearts. Particularly intriguing is the discovery of fibroblast filopodia within the lumen of some of the enlarged t-tubules indicating a possible role in depositing the increased t-tubule Col-VI in heart failure. Both confocal and super-resolution data demonstrate that this increased labelling is associated with an accumulation of Col-VI within the t-tubular lumen. Analysis of the super-resolution images demonstrates a 1.6-fold increase in the Col-VI width in diseased t-tubules (231 nm compared to 370 nm).
If we assume the t-tubules are cylindrical and use Archimedes geometry we calculate a volume increase of 2.6-fold, very similar to the protein expression data ratio of 2.4. Expansion of Col-VI within t-tubules is associated with displacement of the t-tubular membrane as demonstrated by concomitant widening of t-tubules when assessed from the membrane associated labelling of dystrophin. We have previously modelled that lateral disruption of cardiac junctions on the order of $10 nm is sufficient to substantially reduce activation of the calcium release. 15 The changes in t-tubular structure we have documented are on the order of $100 nm and could contribute to the distorted junctional structure previously described by EM. 46 Col-VI is a heterotrimeric molecule with a 1:1:1 ratio of: a1(VI), a2(VI), and a3(VI) chains that assembles into a tetramer, which upon secretion align non-covalently end to end, forming microfibrils in the ECM. 32, 47 More recently an additional three novel alpha chains: a4(VI), a5(VI), and a6(VI) homologous to a3(VI) were discovered. 48, 49 Our LC-MS/MS analysis identified only a1(VI), a2(VI), and a3(VI) chains in the 140 kDa region positive to a1(VI) chain antibody. It is possible that other Col-VI alpha chains are present in our samples outside the 140 kDa region analysed, particularly as western blots to a6(VI) chain have previously detected a 55 kDa band in human heart. 50 The mass spectrometry data also indicate the amount of a3(VI) is approximately half that of a1(VI) and a2(VI). This indicates the involvement of another alpha chain such as a6(VI), which has been shown to have t-tubular location in both skeletal 51 and cardiac muscle (see immunohistochemistry images for Interestingly, mutations in Col-VI are associated with Ulrich congenital muscular dystrophy and Bethlam myopathy indicating an important functional role in muscle. 32 Increased production of Col-VI fibrils by myofibroblasts/fibroblasts could contribute to the distortion in t-tubular structure documented here. 44, 45 Furthermore, our finding of a 3.2-fold increase in WGA binding to Col-VI in heart failure indicates a possible increase in glycosylation that may change structural integrity. Pertinently, glycosylation of hydroxylysines of individual a chains is essential for formation of mature tetramers. 39 Functionally, Col-VI is thought to provide a structural link between myocyte basal lamina and the interstitial matrix. 32 The fact that both mutations in Col-VI and dystrophin can result in muscular dystrophy 29, 32 suggests these molecules are components of the same complex. This is supported by our finding that WGA binds to Col-VI and that this lectin has been used to purify dystrophin from the sarcolemma. 27 Our super-resolution images are consistent with this idea demonstrating on the nano-scale that Col-VI adjacent to the sarcolemma is mirrored by a similar pattern in dystrophin.
Furthermore, biglycan can bind both Col-VI and the DGC 53-55 indicative of a direct mechanical linkage. A proposed model of Col-VI and the DGC organization in cardiac myocytes is presented in Figure 8 . Dystrophin links to both the actin microfilaments and microtubules in the cytoskeleton 56, 57 which in turn links to the L-type Ca 2þ channel. 58 Potentially increased deposition of Col-VI places stress on the dystrophin complex distorting the myocyte cytoskeleton and displacing the alignment of the L-type Ca 2þ channel with the ryanodine receptor within the cardiac junction. This proposition is consistent with defects in the MDX mouse that lacks functional dystrophin. The L-type calcium channels in this animal lose their ability to regulate mitochondrial activity through disruption of the cardiac myocyte cytoskeleton. 58 Furthermore, in heart failure these animals display an abnormal or prolonged cardiac Ca 2þ release. 59 Moreover, a muscular dystrophy patient with a mutation in the a6(VI) chain had greatly reduced L-type Ca 2þ channel and ryanodine receptor labelling. 60 Another aspect of the increased t-tubule collagen that we observe relates to the observation of geometrical deformations of t-tubules in contracting myocytes. 61 This strain-transfer has been proposed to be important for stretch-activated signaling at the t-tubule membrane as well as luminal volume exchange. The increased collagen content in heart failure would be expected to lead to a stiffening of the t-tubules and reduced strain transfer in analogy to the stiffening of heart tissue from interstitial fibrosis. A previous study of Col-VI in human heart failure also demonstrated increased interstitial labelling but, in contrast to our results, noted only an occasional presence of t-tubule labelling. 62 We suspect methodological differences may account for the difference. For example, even moderate over-fixation of tissue can result in loss of Col-VI labelling at ttubules. This would reduce label density preferentially reducing the contrast of smaller (or higher frequency) structures, such as t-tubules. Visualization of faintly labelled t-tubules could also be adversely effected by lens numerical aperture and a low refractive index of the mounting medium, experimental details that were not reported for this previous study on Col-VI in the heart. Subsequently, we examined if the t-tubules contained the basement collagen type IV and the fibrillar collagens type I and III. This analysis demonstrated all three of these collagens were present within the t-tubules, as demonstrated by confocal microscopy and confirmed by higher contrast super-resolution microscopy. Furthermore, in failing hearts the dilated t-tubules identified from dystrophin labelling also had wider labelling pattern for these collagens. This data suggest that these collagens may also contribute to t-tubule remodelling in heart failure, although only a significant increase in interstitial labelling area was documented for Col-I.
In agreement with our findings Kostin et al. 12 have reported the presence of Col-IV within the t-tubules of the human heart. However we could not find any reports for the presence of Col-I and Col-III within ttubules. Although, a previous study reported fine "circumferential" collagen fibres stained by picrosirius red that were perpendicular to the myocyte long axis with regular spacing of 2 mm. Some of these fibres may in fact have been t-tubule collagen similar to what we observe. Interestingly, the authors noted that these collagen fibres were difficult to observe and required increased gain on the confocal system. The difficulties in observing faint t-tubule collagen labelling against a background of intense interstitial labelling have probably resulted in the presence of collagen within the t-tubules being largely overlooked.
Limitations and future directions
An inherent limitation in the current study is that we have examined end-stage human heart failure. It is therefore not possible to determine if handling and contractile function, in response to a suitable intervention would be required to thoroughly test our new hypothesis. However, we believe we have identified a novel potential mechanism that could link tissue level fibrosis with nanoscale disruption of myocyte structure and function that warrants further investigation. In any case, the presence of several collagens and their change in failure that we show here should be considered in continuing attempts to improve the understanding of ttubule turnover, function and loss in cardiac myocytes. For example, an over-expression model of Col-VI in the mouse could be developed to test consequences on t-tubule remodelling. Observations with an existing Col-VI knock-out mouse model are consistent with our hypothesis. Luther and colleagues reported that knock-out animals are paradoxically protected from myocardial infarction as demonstrated by improved ejection fraction, and reduced infarct size relative to wild type animals. 63 Although these authors did not examine t-tubule structure we speculate that the absence of functional Col-VI protects these animals from t-tubular remodelling providing at least some of the observed protection. Supporting this hypothesis, t-tubular changes also appear to be an important feature of ischaemic heart failure. 6, 7 Furthermore, beta blockade with carvedilol reduces both fibrosis 64 and t-tubule remodelling. 65 
Supplementary material
Supplementary material is available at Cardiovascular Research online.
